Corynebacterium jeikeium bacteraemia and pulmonary infiltrates in a patient with acute myelogenous leukaemia.

Abstract

The authors used vancomycin (VCM) to treat Corynebacterium jeikeium bacteraemia and pulmonary infiltrates in a patient with acute myelogenous leukaemia. Pulmonary infiltrates are found in about one-third of patients with haematological pathologies accompanying C jeikeium bacteraemia. Although linezolid and daptomycin are antimicrobial alternatives for treating Corynebacterium infections, the authors believe that VCM is the best choice for immediate treatment success and to prevent pulmonary infiltrates from developing in the presence of bloodstream infection with Corynebacteria in patients with haematological malignancies.

• Authors: Kota Sato, Michihiro Uchiyama
• Journal: BMJ case reports (BMJ Case Rep) Vol. 2012 (Mar 20 2012) ISSN: 1757-790X [Electronic] England
• PMID: 22605704 (Publication Type: Journal Article, Case Reports)

Chemical References

• Anti-Bacterial Agents
• Vancomycin

Topics

• Adolescent
• Anti-Bacterial Agents (therapeutic use)
• Bacteremia (complications, drug therapy, microbiology)
• Corynebacterium (isolation & purification)
• Corynebacterium Infections (complications, drug therapy, microbiology)
• Humans
• Leukemia, Myeloid, Acute (complications, drug therapy)
• Male
• Respiratory Tract Infections (complications, drug therapy, microbiology)
• Tomography, X-Ray Computed
• Vancomycin (therapeutic use)